These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?]. Mehnert H Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320 [No Abstract] [Full Text] [Related]
6. Treating type 2 diabetes: targeting the many causative factors. Sutherland JE; Hoehns JD J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823 [No Abstract] [Full Text] [Related]
7. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
8. [Effect of peroral blood glucose reducing therapy on insulin receptor interactions in patients with type II diabetes mellitus]. Balabolkin MI; Nedosugova LV; Gavriliuk LM; Gincherman LE Ter Arkh; 1983; 55(9):136-40. PubMed ID: 6356436 [No Abstract] [Full Text] [Related]
13. [Prospective studies on the prevention of manifestations of protodiabetes using sulfonylurea compounds and biguanides]. Adolph W; Panzram G; Ruttmann B Z Gesamte Inn Med; 1976 Jan; 31(1):1-6. PubMed ID: 969760 [No Abstract] [Full Text] [Related]
14. [Pharmacologic treatment of diabetes]. De Montigny P; Clerc C; Descarpentries C Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094 [No Abstract] [Full Text] [Related]
15. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents]. Pernet A; Bäbler M; Ganz K Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361 [No Abstract] [Full Text] [Related]
16. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
17. [Simplified combination treatment of diabetes mellitus with sulfonylurea compounds and biguanides]. Bock E Z Allgemeinmed; 1975 Jan; 51(1):37. PubMed ID: 1216880 [No Abstract] [Full Text] [Related]
18. [Oral therapy of type II diabetes]. Haupt E; Schöffling K Med Klin (Munich); 1989 Apr; 84(4):203-7. PubMed ID: 2657363 [No Abstract] [Full Text] [Related]
19. [Possible primary prevention of NIDDM (type 2 diabetes) by pharmacological interventions]. Kawazu S Nihon Rinsho; 1997 Oct; 55 Suppl():354-61. PubMed ID: 9392131 [No Abstract] [Full Text] [Related]
20. [Diabetes mellitus and obesity: monotherapy using biguanides]. Bäbler M Schweiz Med Wochenschr; 1973 Apr; 103(17):641-5. PubMed ID: 4704806 [No Abstract] [Full Text] [Related] [Next] [New Search]